56 related articles for article (PubMed ID: 2011210)
1. Distribution of carbohydrate structures in individual maturation stages of myeloid leukemic cells.
Noworolska A; Slesak B; Harłonzińska A; Richter R
Neoplasma; 1991; 38(1):57-62. PubMed ID: 2011210
[TBL] [Abstract][Full Text] [Related]
2. Distribution of surface nonspecific cross-reacting antigen and influence of proteolytic enzymes on this antigen in myeloid cell series.
Noworolska A; Harłozińska-Szmyrka A; Richter R
Cancer Detect Prev; 1986; 9(3-4):365-71. PubMed ID: 3527416
[TBL] [Abstract][Full Text] [Related]
3. Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series.
Noworolska A; Harłozińska A; Richter R; Brodzka W
Br J Cancer; 1985 Mar; 51(3):371-7. PubMed ID: 3882113
[TBL] [Abstract][Full Text] [Related]
4. Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects.
Noworolska A; Harłozińska A; Buchegger F; Lawińska B; Richter R
Blut; 1989 Feb; 58(2):69-73. PubMed ID: 2920218
[TBL] [Abstract][Full Text] [Related]
5. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.
Geissler K; Tricot G; Leemhuis T; Walker E; Broxmeyer HE
Cancer Res; 1989 Jun; 49(11):3057-62. PubMed ID: 2497971
[TBL] [Abstract][Full Text] [Related]
6. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
[TBL] [Abstract][Full Text] [Related]
7. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
[TBL] [Abstract][Full Text] [Related]
8. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
9. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
Schmetzer HM; Gerhartz HH
Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
[TBL] [Abstract][Full Text] [Related]
10. Study of differentiation of fresh human leukemic cells by low dose cytosine arabinoside (LD Ara-C) and 12-O-tetradecanoylphorbol-13-acetate (TPA).
Kuliczkowski K; Noworolska A; Frydecka I; Sedek K; Harłozińska A
Neoplasma; 1989; 36(5):589-97. PubMed ID: 2812152
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia.
Takasaki Y; Robinson WA; Tan EM
J Natl Cancer Inst; 1984 Sep; 73(3):655-61. PubMed ID: 6147434
[TBL] [Abstract][Full Text] [Related]
12. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
13. Exposure by desialylation of myeloid antigens on acute lymphoblastic leukemia cells.
Stockinger H; Majdic O; Liszka K; Aberer W; Bettelheim P; Lutz D; Knapp W
J Natl Cancer Inst; 1984 Jul; 73(1):7-11. PubMed ID: 6204096
[TBL] [Abstract][Full Text] [Related]
14. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
Andreasen RB; Olsson L
J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis.
Knapp W; Strobl H; Majdic O
Cytometry; 1994 Dec; 18(4):187-98. PubMed ID: 7534675
[TBL] [Abstract][Full Text] [Related]
16. Specificity of heteroantisera to human acute leukemia-associated antigens.
Baker MA; Ramachandar K; Taub RN
J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
[TBL] [Abstract][Full Text] [Related]
17. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
Ball ED; Graziano RF; Fanger MW
J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of myeloid cells in liquid culture: 2. Acute myelocytic leukemia cells.
Archimbaud E; Preisler HD
Cell Biochem Funct; 1987 Jul; 5(3):157-66. PubMed ID: 3475187
[TBL] [Abstract][Full Text] [Related]
19. Binding of lectins to human leukaemic cells.
Slesak B; Bogusławska-Jaworska J; Pejcz J; Harłozińska A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):251-9. PubMed ID: 2475405
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]